Loading
IARC estimates 25,058 new cancer cases and 14,645 cancer deaths in Mozambique in 2024; the commonest new cancers are cervix uteri, Kaposi sarcoma and oesophagus. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Cervix uteri | 5,381 | 45.7 | Cervical cancer |
| Kaposi sarcoma | 4,308 | 15.8 | Kaposi sarcoma |
| Oesophagus | 1,781 | 10.5 | Oesophageal cancer |
| Breast | 1,744 | 15.7 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Liver and intrahepatic bile ducts | 1,616 | 8.0 | Hepatocellular carcinoma |
| Prostate | 1,051 | 20.4 | Prostate cancer |
| Non-Hodgkin lymphoma | 982 | 3.9 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Bladder | 719 | 4.3 | Bladder & urothelial cancer |
| Colorectum | 541 | 3.0 | Colorectal cancer |
| Leukaemia | 458 | 1.6 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Cervix uteri | 3,090 | 26.8 | Cervical cancer |
| Kaposi sarcoma | 1,713 | 6.4 | Kaposi sarcoma |
| Oesophagus | 1,531 | 9.3 | Oesophageal cancer |
| Liver and intrahepatic bile ducts | 1,363 | 7.1 | Hepatocellular carcinoma |
| Breast | 823 | 7.8 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Prostate | 633 | 12.6 | Prostate cancer |
| Non-Hodgkin lymphoma | 439 | 1.9 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Bladder | 378 | 2.5 | Bladder & urothelial cancer |
| Leukaemia | 309 | 1.2 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Colorectum | 284 | 1.7 | Colorectal cancer |
No trial record in OnCo lists a site in Mozambique. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Mozambique.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Mozambique is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Mozambique is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.